(Q40792003)

23 September 2017

title

Active efflux of the 5-HT(1A) receptor agonist flesinoxan via P-glycoprotein at the blood-brain barrier (English)

1 reference

23 September 2017

1 reference

van der Sandt IC

1

1 reference

23 September 2017

Smolders R

2

1 reference

23 September 2017

Nabulsi L

3

1 reference

23 September 2017

Zuideveld KP

4

1 reference

23 September 2017

de Boer AG

5

1 reference

23 September 2017

Breimer DD

6

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

European Journal of Pharmaceutical Sciences

23 September 2017

published in

1 reference

23 September 2017

volume

14

1 reference

23 September 2017

issue

1

1 reference

23 September 2017

page(s)

81-86

1 reference

Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900150-6

7 January 2021

The effects of the 5-HT1A agonist flesinoxan, in three paradigms for assessing antidepressant potential in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900150-6

7 January 2021

Effect of the P-glycoprotein inhibitor, SDZ PSC 833, on the blood and brain pharmacokinetics of colchicine

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900150-6

7 January 2021

Astrocytes increase the functional expression of P-glycoprotein in an in vitro model of the blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900150-6

7 January 2021

Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900150-6

7 January 2021

Saturable P-glycoprotein kinetics assayed by fluorescence studies of drug efflux from suspended human KB8-5 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900150-6

7 January 2021

Characterization of 5-hydroxytryptamine1A properties of flesinoxan: in vivo electrophysiology and hypothermia study

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900150-6

7 January 2021

Role of blood-brain barrier P-glycoprotein in limiting brain accumulation and sedative side-effects of asimadoline, a peripherally acting analgaesic drug

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900150-6

7 January 2021

Cell Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian Cell Lines

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900150-6

7 January 2021

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900150-6

7 January 2021

Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900150-6

7 January 2021

Early penetration of the blood-brain-barrier by HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900150-6

7 January 2021

Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900150-6

7 January 2021

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900150-6

7 January 2021

Multidrug resistance and the role of P-glycoprotein knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900150-6

7 January 2021

P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900150-6

7 January 2021

Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900150-6

7 January 2021

Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood--brain barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900150-6

7 January 2021

10.1016/S0928-0987(01)00150-6

Identifiers

DOI

1 reference

release_dkhvjhx5ebdkvcupnkit7qdprm

23 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dkhvjhx5ebdkvcupnkit7qdprm

24 November 2022

mapped directly with Wikidata item

1 reference